Bloomios, Inc. announced that it has entered into a securities purchase agreement with non-affiliated accredited investor for a private placement of a convertible promissory note for gross proceeds of $250,000 on November 30, 2021. The note will be issued at a discount of $25,000 to face value of $275,000. The note carries a fixed coupon of 10% per annum and will mature in 9 months from the date of issue on August 29, 2022. The note will be convertible into common shares at a fixed conversion price of $1.08 per share. The note provides that the investor may not convert any amount of the note that would result in the beneficial ownership of greater than 4.99% of the outstanding shares of the company, with the exception that the beneficial ownership limitation may be waived up to a maximum of 9.99% at the election of the investor, with not less than 61 days prior notice. In addition, the company also issued 250,000 warrants to issuer which are exercisable having a term of 60 months at an exercise price of $1.08. The warrants are convertible into common stock of the company. The securities are subject to exemption provided under the Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D.